CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized, Controlled, Dose Escalation Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of WRAIR's AMA-1 Malaria Vaccine (FMP2.1) Adjuvanted in GSKBio's AS02A Vs. Rabies Vaccine in 1-6 Year Old Children in Bandiagara, Mali

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00358332
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:15.047085+00:00
Published At: 2009-03-04T00:00:00+00:00
Record Updated At: 2011-10-24
Results Posted At: 2009-03-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Plasmodium Falciparum Malaria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2011-10-24"
protocolSection.identificationModule.nctId: "NCT00358332"
protocolSection.identificationModule.officialTitle: "Randomized, Controlled, Dose Escalation Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of WRAIR\u0027s AMA-1 Malaria Vaccine (FMP2.1) Adjuvanted in GSKBio\u0027s AS02A Vs. Rabies Vaccine in 1-6 Year Old Children in Bandiagara, Mali"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2009-03-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.